Including neuro-metabolic conditions, neuromuscular conditions, neurogenetic conditions, microcephaly, Alzheimer disease, CADASIL, Huntington disease, other neurology sites
References:
Edwardson, J., & Morris, C. (1998). The genetics of Alzheimer's
disease. The number of genetic risk factors associated with this disorder
is increasing steadily [editorial]. Bmj, 317(7155):361-2
Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A.,
Mayeux, R., Myers, R. H., Pericak-Vance, M. A., Risch, N., & van Duijn,
C. M. (1997). Effects of age, sex, and ethnicity on the association between
apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and
Alzheimer Disease Meta Analysis Consortium [see comments]. Journal of
the American Medical Association, 278(16):1349-56
Hardy, J., & Gwinn-Hardy, K. (1998). Genetic classification of primary
neurodegenerative disease. Science, 282(5391):1075-9
Lendon, C. L., Ashall, F., & Goate, A. M. (1997). Exploring the etiology
of Alzheimer disease using molecular genetics. Journal of the American
Medical Association, 277(10):825-31
Kukull, W. A., & Martin, G. M. (1998). APOE polymorphisms and late-onset
Alzheimer disease: the importance of ethnicity [editorial; comment]. Jama,
279(10):788-9
Farrer, L. A., Cupples, L. A., Haines, J. L., Hyman, B., Kukull, W. A.,
Mayeux, R., Myers, R. H., Pericak-Vance, M. A., Risch, N., & van Duijn,
C. M. (1997). Effects of age, sex, and ethnicity on the association between
apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and
Alzheimer Disease Meta Analysis Consortium [see comments]. Journal of
the American Medical Association, 278(16):1349-56
Mayeux, R., Saunders, A. M., Shea, S., Mirra, S., Evans, D., Roses, A. D.,
Hyman, B. T., Crain, B., Tang, M. X., & Phelps, C. H. (1998). Utility
of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease.
Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's
Disease [published erratum appears in N Engl J Med 1998 Apr 30;338(18):1325]
[see comments]. New England Journal of Medicine, 338(8):506-11
Post, S. G., Whitehouse, P. J., Binstock, R. H., Bird, T. D., Eckert, S.
K., Farrer, L. A., Fleck, L. M., Gaines, A. D., Juengst, E. T., Karlinsky,
H., Miles, S., Murray, T. H., Quaid, K. A., Relkin, N. R., Roses, A. D.,
St. George-Hyslop, P. H., Sachs, G. A., Steinbock, B., Truschke, E. F.,
& Zinn, A. B. (1997). The clinical introduction of genetic testing for
Alzheimer disease. An ethical perspective [see comments]. Jama, 277(10):832-6
Thinakaran, G. (1999). The role of presenilins in Alzheimer's disease. Journal
of Clinical Investigation, 104(10):1321-7
CADASIL
Revised January , 2011
This site complies with the HONcode standard for trustworthy health information:
verify here.